Earnings Feed
Start Free
Home/Filings/4/0001209191-09-057844
4//SEC Filing

Miller Dennis M. 4

Accession 0001209191-09-057844

CIK 0001129425other
View on SEC.govCompany Profile

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 1:46 PM ET

Size

25.9 KB

Accession

0001209191-09-057844

Insider Transaction Report

Form 4
Period: 2009-12-16
ZYMOGENETICS INCZGEN
Miller Dennis M.
Sr VP, Resrch & Preclin Devl
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-12-16−6,500→ 0 total
    Exercise: $15.91Exp: 2017-02-05→ Common Stock (6,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2009-12-16+6,000→ 35,484 total
    Exercise: $6.35Exp: 2016-12-16→ Common Stock (6,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2009-12-16+7,142→ 29,484 total
    Exercise: $6.35Exp: 2016-12-16→ Common Stock (7,142 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-12-16−12,500→ 0 total
    Exercise: $15.11Exp: 2017-06-21→ Common Stock (12,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2009-12-16+3,200→ 18,628 total
    Exercise: $6.35Exp: 2016-12-16→ Common Stock (3,200 underlying)
  • Award

    Stock Option (Right to Buy)

    2009-12-16+3,714→ 22,342 total
    Exercise: $6.35Exp: 2016-12-16→ Common Stock (3,714 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-12-16−27,000→ 0 total
    Exercise: $15.44Exp: 2015-03-31→ Common Stock (27,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-12-16−7,500→ 0 total
    Exercise: $9.10Exp: 2018-02-15→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-12-16−8,000→ 0 total
    Exercise: $21.25Exp: 2016-02-08→ Common Stock (8,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2009-12-16+15,428→ 15,428 total
    Exercise: $6.35Exp: 2016-12-16→ Common Stock (15,428 underlying)
Footnotes (4)
  • [F1]The option provided for vesting over four years at the rate of 25% after one year and 6.25% every three months thereafter.
  • [F2]On December 16, 2009, pursuant to an option exchange program, the issuer cancelled an existing option to purchase ZGEN common stock granted to the reporting person. In exchange, the reporting person received a replacement option for a lesser number of shares, having an exercise price of $6.35 per share.
  • [F3]The option vests over two years, 50% after one year with the remainder vesting thereafter in four equal quarterly installments.
  • [F4]The option vests over three years, one-third after one year with the remainder vesting thereafter in eight equal quarterly installments.

Documents

1 file

Issuer

ZYMOGENETICS INC

CIK 0001129425

→
Entity typeother

Related Parties

1
  • filerCIK 0001472555

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 1:46 PM ET
Size
25.9 KB
View on SEC.gov